Anaptysbio, Inc SEC filings ANAB
Anaptysbio, Inc has 725 filings in SEC EDGAR's recent list, going back to Jul 6, 2006. Its latest annual report, Form 10-KT, was filed on Sep 21, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 15, 2024 | — |
| CORRESP | Letter to the SEC | Nov 13, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2024 | — |
| EFFECT | Filing | Jan 11, 2022 | — |
| CORRESP | Letter to the SEC | Jan 7, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2018 | — |
| CORRESP | Letter to the SEC | Sep 19, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2018 | — |
| EFFECT | Filing | Oct 12, 2017 | — |
| CORRESP | Letter to the SEC | Oct 10, 2017 | — |
| CORRESP | Letter to the SEC | Oct 10, 2017 | — |
| CORRESP | Letter to the SEC | Oct 10, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2017 | — |
| DRS | Filing | Sep 11, 2017 | — |
| CT ORDER | Filing | Jan 27, 2017 | — |
| POS EX | Filing | Jan 26, 2017 | — |
| EFFECT | Filing | Jan 25, 2017 | — |
| CERTNAS | Auto-generated paper document | Jan 24, 2017 | — |
| CORRESP | Letter to the SEC | Jan 23, 2017 | — |
| CORRESP | Letter to the SEC | Jan 23, 2017 | — |
| 8-A12B | Filing | Jan 17, 2017 | — |
| CORRESP | Letter to the SEC | Jan 10, 2017 | — |
| CORRESP | Letter to the SEC | Dec 28, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2016 | — |
| CORRESP | Letter to the SEC | Mar 22, 2016 | — |
| CORRESP | Letter to the SEC | Jan 11, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 7, 2016 | — |
| CORRESP | Letter to the SEC | Sep 24, 2015 | — |
| CORRESP | Letter to the SEC | Sep 9, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2015 | — |
| DRSLTR | Filing | Aug 18, 2015 | — |
| DRS/A | Filing | Aug 18, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2015 | — |
| D | Filing | Jul 24, 2015 | — |
| DRS | Filing | Jul 17, 2015 | — |
| D | Filing | Oct 10, 2013 | — |
| D | Filing | Oct 14, 2011 | — |
| D | Filing | Feb 7, 2011 | — |
| D | Filing | Oct 21, 2010 | — |
| REGDEX | Auto-generated paper document | Aug 27, 2008 | — |
| REGDEX | Auto-generated paper document | Nov 20, 2007 | — |
| REGDEX | Auto-generated paper document | Jun 8, 2007 | — |
| REGDEX | Auto-generated paper document | Feb 22, 2007 | — |
| REGDEX | Auto-generated paper document | Sep 18, 2006 | — |
| REGDEX | Auto-generated paper document | Aug 24, 2006 | — |
| REGDEX | Auto-generated paper document | Jul 6, 2006 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANAB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1370053
- Former names
- ANAPTYSBIO INC (until Jun 12, 2019); ANAPTYS BIOSCIENCES INC (until Nov 20, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.